Review the entire market. Not just your inbox.
A single thesis, applied to every company in your sector, the same way every time. From the whole market to a defensible shortlist in hours, not quarters.
Scale like a team many times your size.
Every fund means to review its whole sector. In practice, a lean team only opens the deals that reach its inbox — and you can’t hire analysts fast enough to cover the rest. FlowHive gives you that reach now: the entire field, evaluated against your thesis the same way every time.
Warm intros show a sliver.
The deals that reach your inbox came through someone you already know. The rest of your sector — the companies nobody forwarded — never surfaces.
Hand triage caps at headcount.
Excel and a couple of analysts can only open so many companies a quarter. A bigger team reaches further — but the manual work still doesn’t scale.
More hands, more interpretations.
Adding people extends your reach, but every reviewer reads the thesis a little differently. Wider coverage shouldn’t cost you a consistent answer.
Signal tools find hot deals. They don’t apply your thesis.
Doesn’t scale, enforces no thesis, and learns nothing between batches.
Excellent at surfacing signals — great as input to FlowHive. But they don’t encode your investment criteria.
A thesis written once and read by nobody. Applied inconsistently, person to person.
FlowHive sits downstream of signal tools and upstream of your CRM — the layer where your thesis becomes enforceable.
From your whole sector to an IC-ready shortlist.
Thesis-driven filtering at scale — your DNA applied to the whole field, not a hand-picked sample. Stage 1 is live today; the deeper stages roll out from there.
Encode your thesis as VC DNA
Industries, focus, business model, stage, geography, customer type — and, for CVCs, strategic-fit constraints.
Ingest the full sector universe
Bring your market in from PitchBook, Crunchbase, Dealroom, or a manual import. The whole field, not a sample.
Evaluate every company against every rule
Consistent, reproducible verdicts — each with a written, per-criterion reason you can read.
Advance only the strongest
The companies that actually fit your thesis move to deeper research. The rest are filtered out, with a rationale.
Your whole sector, straight from the data you already license — every company you could conceivably look at.
What full coverage looks like.
Consistent. Reproducible. Auditable.
Same thesis, same verdict.
Run it today or next quarter, by an analyst or a partner — the same thesis produces the same answer.
A reason behind every call.
Every advance and every kill carries a written, per-criterion rationale. No black-box scores.
Defensible end to end.
Reviews you can reproduce and stand behind — to your IC, your LPs, and the parent company.
Coverage, with a paper trail.
Full sector universe
Every company in your scope evaluated against your thesis — not just the few your team had time to open.
One firm-wide standard
The same DNA produces the same answer, regardless of who clicked run. Your thesis, enforced.
Reasons attached to every verdict
Per-criterion rationale, ready for the questions IC, LPs, and the parent company will ask.
The rest of the platform.
Deep Deal Research
Founder, market, competitor, and regulatory context attached before the meeting.
Learn moreInvestment Thesis as Code
Your investment thesis as code — encoded, versioned, and sharper with every override.
Learn moreBuilt for Corporate VCs
Parent-company strategic fit as a first-class evaluation dimension.
Learn moreSee your sector get filtered in real time.
Bring your sector. We’ll run Stage 1 on a sample batch during the demo and walk you through every verdict.